These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9152365)

  • 1. Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits the binding of N-formylmethionyl-leucyl-phenylalanine to neutrophil receptors.
    Raiden S; Giordano M; Andonegui G; Trevani AS; López DH; Nahmod V; Geffner JR
    J Pharmacol Exp Ther; 1997 May; 281(2):624-8. PubMed ID: 9152365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits neutrophil recruitment in the lung triggered by fMLP.
    Raiden S; Pereyra Y; Nahmod V; Alvarez C; Castello L; Giordano M; Geffner J
    J Leukoc Biol; 2000 Nov; 68(5):700-6. PubMed ID: 11073110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome.
    Raiden S; Nahmod K; Nahmod V; Semeniuk G; Pereira Y; Alvarez C; Giordano M; Geffner JR
    J Pharmacol Exp Ther; 2002 Oct; 303(1):45-51. PubMed ID: 12235231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diversified pharmacology of angiotensin II-receptor blockade.
    Timmermans PB; Smith RD
    Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II antagonists: a new class of antihypertensive agent.
    Waeber B; Brunner HR
    Br J Clin Pract; 1996; 50(5):265-8. PubMed ID: 8794603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of putative glomerular receptors for angiotensin II in the rainbow trout Oncorhynchus mykiss using the antagonists Losartan, PD 123177, and saralasin.
    Cobb CS; Brown JA
    Gen Comp Endocrinol; 1993 Oct; 92(1):123-31. PubMed ID: 8262354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Historical development of losartan (DuP 753) and angiotensin II receptor subtypes.
    Wong PC; Timmermans PB
    Blood Press Suppl; 1996; 3():11-4. PubMed ID: 8973760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-hypertensive therapy by losartan. How effective is AT1 receptor blockade?
    Brunner HR
    J Hum Hypertens; 1995 Nov; 9(11):859-60. PubMed ID: 8583462
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of angiotensin receptor blockade in the rabbit aorta: influence of the endothelium.
    le Tran Y; Forster C
    Can J Physiol Pharmacol; 1996 Dec; 74(12):1277-86. PubMed ID: 9047036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New angiotensin-II blocker.
    Lilley LL; Guanci R
    Am J Nurs; 1996 Mar; 96(3):20. PubMed ID: 8607540
    [No Abstract]   [Full Text] [Related]  

  • 11. Losartan (Cozaar).
    Baldinger S
    Conn Med; 1996 May; 60(5):281-4. PubMed ID: 8998906
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin antagonists.
    Brunner HR; Nussberger J; Waeber B
    Adv Nephrol Necker Hosp; 1993; 22():305-27. PubMed ID: 8427061
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antagonists of angiotensin II receptor].
    Karasek D; Adamski M; Grzeszczak W
    Postepy Hig Med Dosw; 1996; 50(1):21-32. PubMed ID: 8778711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Losartan. The first non-peptide angiotensin II receptor antagonist for treatment of hypertension].
    Ibsen H; Rasmussen S; Slatanach R
    Ugeskr Laeger; 1996 Jun; 158(26):3798-802. PubMed ID: 8686080
    [No Abstract]   [Full Text] [Related]  

  • 15. A new antihypertensive class: the angiotensin receptor antagonist.
    Kupecz D
    Nurse Pract; 1996 Mar; 21(3):106, 109, 113-4. PubMed ID: 8710244
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
    Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF
    Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How well have animal studies with losartan predicted responses in humans?
    Sweet CS; Nelson EB
    J Hypertens Suppl; 1993 Apr; 11(3):S63-7. PubMed ID: 8315522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic, pharmacokinetic and clinical profile of the first orally active angiotensin II receptor antagonist.
    Reid JL
    Cardiologia; 1995 Dec; 40(12 Suppl 1):187. PubMed ID: 8903052
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective antagonism of the AT1 receptor inhibits the effect of angiotensin II on DNA and protein synthesis of rat proximal tubular cells.
    Weerackody RP; Chatterjee PK; Mistry SK; McLaren J; Hawksworth GM; McLay JS
    Exp Nephrol; 1997; 5(3):253-62. PubMed ID: 9208286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transposition of the imidazole ring substituents of angiotensin mimetics related to Losartan.
    Smith JR; Wahhab A; Moore D; Ganter RC; Moore GJ
    Drug Des Discov; 1994 Nov; 12(2):113-9. PubMed ID: 9116166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.